Skip to Content

GSI 255 (Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg)

Generic Name: emtricitabine/rilpivirine/tenofovir alafenamide

Pill imprint GSI 255 has been identified as Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg.

Odefsey is used in the treatment of hiv infection Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg is classified as a Schedule U controlled substance under the Controlled Substance Act (CSA).

Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg GSI 255
Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg GSI 255
Discount Card Promo
Odefsey
Generic Name:
emtricitabine/rilpivirine/tenofovir alafenamide
Imprint:
GSI 255
Strength:
emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg
Color:
Gray
Shape:
Capsule-shape
Availability:
Prescription only
CSA Schedule:
U - Unknown
Manufacturer:
Gilead Sciences, Inc.

More info Print Imprint Search

More about Odefsey (emtricitabine / rilpivirine / tenofovir alafenamide)

Consumer resources

Professional resources

Related treatment guides

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide